nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—hematopoietic system—stomach cancer	0.00129	0.201	CbGeAlD
Acamprosate—GRM5—endocrine gland—stomach cancer	0.000744	0.115	CbGeAlD
Acamprosate—SLC36A1—pancreas—stomach cancer	0.000551	0.0856	CbGeAlD
Acamprosate—SLC36A1—digestive system—stomach cancer	0.000471	0.0731	CbGeAlD
Acamprosate—GRIN1—endocrine gland—stomach cancer	0.000469	0.0729	CbGeAlD
Acamprosate—GRIN2B—endocrine gland—stomach cancer	0.000448	0.0695	CbGeAlD
Acamprosate—SLC36A1—bone marrow—stomach cancer	0.000434	0.0674	CbGeAlD
Acamprosate—Dizziness—Fluorouracil—stomach cancer	0.000433	0.0006	CcSEcCtD
Acamprosate—Visual impairment—Epirubicin—stomach cancer	0.000432	0.000599	CcSEcCtD
Acamprosate—Rash—Irinotecan—stomach cancer	0.000431	0.000597	CcSEcCtD
Acamprosate—Dermatitis—Irinotecan—stomach cancer	0.000431	0.000596	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000431	0.000596	CcSEcCtD
Acamprosate—Chills—Methotrexate—stomach cancer	0.00043	0.000596	CcSEcCtD
Acamprosate—Headache—Irinotecan—stomach cancer	0.000428	0.000593	CcSEcCtD
Acamprosate—Hypotension—Capecitabine—stomach cancer	0.000428	0.000592	CcSEcCtD
Acamprosate—Insomnia—Docetaxel—stomach cancer	0.000427	0.000592	CcSEcCtD
Acamprosate—Paraesthesia—Docetaxel—stomach cancer	0.000424	0.000588	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—stomach cancer	0.000424	0.000587	CcSEcCtD
Acamprosate—Dyspnoea—Docetaxel—stomach cancer	0.000421	0.000583	CcSEcCtD
Acamprosate—Somnolence—Docetaxel—stomach cancer	0.00042	0.000582	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—stomach cancer	0.00042	0.000582	CcSEcCtD
Acamprosate—Tinnitus—Epirubicin—stomach cancer	0.000418	0.000579	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—stomach cancer	0.000417	0.000578	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—stomach cancer	0.000417	0.000578	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000417	0.000577	CcSEcCtD
Acamprosate—Vomiting—Fluorouracil—stomach cancer	0.000416	0.000576	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—stomach cancer	0.000416	0.000576	CcSEcCtD
Acamprosate—Dyspepsia—Docetaxel—stomach cancer	0.000416	0.000576	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—stomach cancer	0.000415	0.000575	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—stomach cancer	0.000415	0.000575	CcSEcCtD
Acamprosate—Insomnia—Capecitabine—stomach cancer	0.000414	0.000573	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—stomach cancer	0.000413	0.000572	CcSEcCtD
Acamprosate—Rash—Fluorouracil—stomach cancer	0.000413	0.000572	CcSEcCtD
Acamprosate—Dermatitis—Fluorouracil—stomach cancer	0.000412	0.000571	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—stomach cancer	0.000412	0.00057	CcSEcCtD
Acamprosate—Paraesthesia—Capecitabine—stomach cancer	0.000411	0.000569	CcSEcCtD
Acamprosate—Decreased appetite—Docetaxel—stomach cancer	0.000411	0.000569	CcSEcCtD
Acamprosate—Headache—Fluorouracil—stomach cancer	0.00041	0.000568	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—stomach cancer	0.000409	0.000566	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—stomach cancer	0.000409	0.000566	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000408	0.000565	CcSEcCtD
Acamprosate—Dyspnoea—Capecitabine—stomach cancer	0.000408	0.000565	CcSEcCtD
Acamprosate—Nausea—Irinotecan—stomach cancer	0.000406	0.000562	CcSEcCtD
Acamprosate—Immune system disorder—Epirubicin—stomach cancer	0.000405	0.000561	CcSEcCtD
Acamprosate—Constipation—Docetaxel—stomach cancer	0.000404	0.00056	CcSEcCtD
Acamprosate—Pain—Docetaxel—stomach cancer	0.000404	0.00056	CcSEcCtD
Acamprosate—Back pain—Methotrexate—stomach cancer	0.000404	0.000559	CcSEcCtD
Acamprosate—Dyspepsia—Capecitabine—stomach cancer	0.000403	0.000558	CcSEcCtD
Acamprosate—Chills—Epirubicin—stomach cancer	0.000403	0.000557	CcSEcCtD
Acamprosate—Visual impairment—Doxorubicin—stomach cancer	0.0004	0.000554	CcSEcCtD
Acamprosate—Decreased appetite—Capecitabine—stomach cancer	0.000398	0.000551	CcSEcCtD
Acamprosate—Alopecia—Epirubicin—stomach cancer	0.000396	0.000549	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000395	0.000547	CcSEcCtD
Acamprosate—Mental disorder—Epirubicin—stomach cancer	0.000393	0.000544	CcSEcCtD
Acamprosate—GRIN2A—endocrine gland—stomach cancer	0.000391	0.0608	CbGeAlD
Acamprosate—Pain—Capecitabine—stomach cancer	0.000391	0.000542	CcSEcCtD
Acamprosate—Constipation—Capecitabine—stomach cancer	0.000391	0.000542	CcSEcCtD
Acamprosate—Malnutrition—Epirubicin—stomach cancer	0.000391	0.000541	CcSEcCtD
Acamprosate—Feeling abnormal—Docetaxel—stomach cancer	0.000389	0.000539	CcSEcCtD
Acamprosate—SLC36A1—endocrine gland—stomach cancer	0.000389	0.0604	CbGeAlD
Acamprosate—Nausea—Fluorouracil—stomach cancer	0.000389	0.000538	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—stomach cancer	0.000387	0.000536	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—stomach cancer	0.000387	0.000536	CcSEcCtD
Acamprosate—Gastrointestinal pain—Docetaxel—stomach cancer	0.000386	0.000535	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—stomach cancer	0.000386	0.000534	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—stomach cancer	0.000385	0.000533	CcSEcCtD
Acamprosate—Tension—Epirubicin—stomach cancer	0.000383	0.000531	CcSEcCtD
Acamprosate—Dysgeusia—Epirubicin—stomach cancer	0.000382	0.00053	CcSEcCtD
Acamprosate—Nervousness—Epirubicin—stomach cancer	0.000379	0.000525	CcSEcCtD
Acamprosate—Back pain—Epirubicin—stomach cancer	0.000378	0.000523	CcSEcCtD
Acamprosate—Feeling abnormal—Capecitabine—stomach cancer	0.000377	0.000522	CcSEcCtD
Acamprosate—Malaise—Methotrexate—stomach cancer	0.000376	0.000521	CcSEcCtD
Acamprosate—Muscle spasms—Epirubicin—stomach cancer	0.000376	0.00052	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—stomach cancer	0.000375	0.000519	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—stomach cancer	0.000375	0.000519	CcSEcCtD
Acamprosate—Gastrointestinal pain—Capecitabine—stomach cancer	0.000374	0.000518	CcSEcCtD
Acamprosate—Abdominal pain—Docetaxel—stomach cancer	0.000374	0.000517	CcSEcCtD
Acamprosate—Body temperature increased—Docetaxel—stomach cancer	0.000374	0.000517	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—stomach cancer	0.000374	0.000517	CcSEcCtD
Acamprosate—Chills—Doxorubicin—stomach cancer	0.000373	0.000516	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—stomach cancer	0.000367	0.000508	CcSEcCtD
Acamprosate—Cough—Methotrexate—stomach cancer	0.000364	0.000504	CcSEcCtD
Acamprosate—Mental disorder—Doxorubicin—stomach cancer	0.000364	0.000504	CcSEcCtD
Acamprosate—Urticaria—Capecitabine—stomach cancer	0.000363	0.000503	CcSEcCtD
Acamprosate—Ill-defined disorder—Epirubicin—stomach cancer	0.000362	0.000502	CcSEcCtD
Acamprosate—Abdominal pain—Capecitabine—stomach cancer	0.000362	0.000501	CcSEcCtD
Acamprosate—Body temperature increased—Capecitabine—stomach cancer	0.000362	0.000501	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—stomach cancer	0.000362	0.000501	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—stomach cancer	0.000361	0.0005	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—stomach cancer	0.000361	0.0005	CcSEcCtD
Acamprosate—Agitation—Epirubicin—stomach cancer	0.000359	0.000497	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—stomach cancer	0.000356	0.000493	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—stomach cancer	0.000355	0.000492	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—stomach cancer	0.000355	0.000492	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—stomach cancer	0.000355	0.000492	CcSEcCtD
Acamprosate—Tension—Doxorubicin—stomach cancer	0.000355	0.000491	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—stomach cancer	0.000354	0.00049	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000353	0.000489	CcSEcCtD
Acamprosate—Malaise—Epirubicin—stomach cancer	0.000352	0.000488	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—stomach cancer	0.000351	0.000486	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—stomach cancer	0.000351	0.000486	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—stomach cancer	0.000351	0.000486	CcSEcCtD
Acamprosate—SLC36A1—liver—stomach cancer	0.000351	0.0545	CbGeAlD
Acamprosate—Syncope—Epirubicin—stomach cancer	0.00035	0.000485	CcSEcCtD
Acamprosate—Leukopenia—Epirubicin—stomach cancer	0.00035	0.000484	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—stomach cancer	0.00035	0.000484	CcSEcCtD
Acamprosate—Hypersensitivity—Docetaxel—stomach cancer	0.000348	0.000482	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—stomach cancer	0.000347	0.000481	CcSEcCtD
Acamprosate—Palpitations—Epirubicin—stomach cancer	0.000345	0.000478	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—stomach cancer	0.000343	0.000476	CcSEcCtD
Acamprosate—Loss of consciousness—Epirubicin—stomach cancer	0.000343	0.000475	CcSEcCtD
Acamprosate—Cough—Epirubicin—stomach cancer	0.000341	0.000472	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—stomach cancer	0.000341	0.000472	CcSEcCtD
Acamprosate—Asthenia—Docetaxel—stomach cancer	0.000339	0.000469	CcSEcCtD
Acamprosate—Convulsion—Epirubicin—stomach cancer	0.000338	0.000469	CcSEcCtD
Acamprosate—Infection—Methotrexate—stomach cancer	0.000338	0.000469	CcSEcCtD
Acamprosate—Hypertension—Epirubicin—stomach cancer	0.000337	0.000467	CcSEcCtD
Acamprosate—Hypersensitivity—Capecitabine—stomach cancer	0.000337	0.000467	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—stomach cancer	0.000335	0.000464	CcSEcCtD
Acamprosate—Pruritus—Docetaxel—stomach cancer	0.000334	0.000463	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—stomach cancer	0.000334	0.000462	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—stomach cancer	0.000334	0.000462	CcSEcCtD
Acamprosate—Myalgia—Epirubicin—stomach cancer	0.000333	0.00046	CcSEcCtD
Acamprosate—Chest pain—Epirubicin—stomach cancer	0.000333	0.00046	CcSEcCtD
Acamprosate—Arthralgia—Epirubicin—stomach cancer	0.000333	0.00046	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—stomach cancer	0.000332	0.00046	CcSEcCtD
Acamprosate—Anxiety—Epirubicin—stomach cancer	0.000331	0.000459	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—stomach cancer	0.000331	0.000458	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00033	0.000457	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—stomach cancer	0.000329	0.000456	CcSEcCtD
Acamprosate—Discomfort—Epirubicin—stomach cancer	0.000329	0.000455	CcSEcCtD
Acamprosate—Asthenia—Capecitabine—stomach cancer	0.000328	0.000455	CcSEcCtD
Acamprosate—Malaise—Doxorubicin—stomach cancer	0.000326	0.000451	CcSEcCtD
Acamprosate—Dry mouth—Epirubicin—stomach cancer	0.000325	0.00045	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—stomach cancer	0.000325	0.00045	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—stomach cancer	0.000325	0.00045	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—stomach cancer	0.000324	0.000449	CcSEcCtD
Acamprosate—Pruritus—Capecitabine—stomach cancer	0.000324	0.000448	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—stomach cancer	0.000323	0.000448	CcSEcCtD
Acamprosate—Diarrhoea—Docetaxel—stomach cancer	0.000323	0.000448	CcSEcCtD
Acamprosate—Confusional state—Epirubicin—stomach cancer	0.000321	0.000445	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—stomach cancer	0.000319	0.000442	CcSEcCtD
Acamprosate—Anaphylactic shock—Epirubicin—stomach cancer	0.000319	0.000441	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—stomach cancer	0.000318	0.000441	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—stomach cancer	0.000318	0.00044	CcSEcCtD
Acamprosate—Infection—Epirubicin—stomach cancer	0.000317	0.000438	CcSEcCtD
Acamprosate—Cough—Doxorubicin—stomach cancer	0.000315	0.000437	CcSEcCtD
Acamprosate—Shock—Epirubicin—stomach cancer	0.000314	0.000434	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—stomach cancer	0.000313	0.000434	CcSEcCtD
Acamprosate—Diarrhoea—Capecitabine—stomach cancer	0.000313	0.000433	CcSEcCtD
Acamprosate—Dizziness—Docetaxel—stomach cancer	0.000313	0.000433	CcSEcCtD
Acamprosate—Thrombocytopenia—Epirubicin—stomach cancer	0.000312	0.000432	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—stomach cancer	0.000312	0.000432	CcSEcCtD
Acamprosate—Tachycardia—Epirubicin—stomach cancer	0.000311	0.000431	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00031	0.00043	CcSEcCtD
Acamprosate—Skin disorder—Epirubicin—stomach cancer	0.00031	0.000429	CcSEcCtD
Acamprosate—Hyperhidrosis—Epirubicin—stomach cancer	0.000308	0.000427	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—stomach cancer	0.000308	0.000427	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—stomach cancer	0.000308	0.000426	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—stomach cancer	0.000308	0.000426	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—stomach cancer	0.000308	0.000426	CcSEcCtD
Acamprosate—Anxiety—Doxorubicin—stomach cancer	0.000307	0.000425	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—stomach cancer	0.000306	0.000423	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000306	0.000423	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—stomach cancer	0.000304	0.000421	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—stomach cancer	0.000304	0.000421	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—stomach cancer	0.000304	0.00042	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—stomach cancer	0.000303	0.000419	CcSEcCtD
Acamprosate—Dizziness—Capecitabine—stomach cancer	0.000303	0.000419	CcSEcCtD
Acamprosate—Dry mouth—Doxorubicin—stomach cancer	0.000301	0.000417	CcSEcCtD
Acamprosate—Vomiting—Docetaxel—stomach cancer	0.0003	0.000416	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—stomach cancer	0.0003	0.000415	CcSEcCtD
Acamprosate—Rash—Docetaxel—stomach cancer	0.000298	0.000413	CcSEcCtD
Acamprosate—Hypotension—Epirubicin—stomach cancer	0.000298	0.000412	CcSEcCtD
Acamprosate—Dermatitis—Docetaxel—stomach cancer	0.000298	0.000412	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—stomach cancer	0.000297	0.000412	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—stomach cancer	0.000296	0.00041	CcSEcCtD
Acamprosate—Headache—Docetaxel—stomach cancer	0.000296	0.00041	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—stomach cancer	0.000295	0.000408	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000294	0.000407	CcSEcCtD
Acamprosate—Infection—Doxorubicin—stomach cancer	0.000293	0.000406	CcSEcCtD
Acamprosate—Pain—Methotrexate—stomach cancer	0.000291	0.000403	CcSEcCtD
Acamprosate—Vomiting—Capecitabine—stomach cancer	0.000291	0.000403	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00029	0.000402	CcSEcCtD
Acamprosate—Shock—Doxorubicin—stomach cancer	0.00029	0.000402	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—stomach cancer	0.000289	0.0004	CcSEcCtD
Acamprosate—Rash—Capecitabine—stomach cancer	0.000289	0.000399	CcSEcCtD
Acamprosate—Insomnia—Epirubicin—stomach cancer	0.000288	0.000399	CcSEcCtD
Acamprosate—Dermatitis—Capecitabine—stomach cancer	0.000288	0.000399	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—stomach cancer	0.000288	0.000399	CcSEcCtD
Acamprosate—Headache—Capecitabine—stomach cancer	0.000287	0.000397	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—stomach cancer	0.000286	0.000397	CcSEcCtD
Acamprosate—Paraesthesia—Epirubicin—stomach cancer	0.000286	0.000396	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—stomach cancer	0.000285	0.000395	CcSEcCtD
Acamprosate—Dyspnoea—Epirubicin—stomach cancer	0.000284	0.000393	CcSEcCtD
Acamprosate—Somnolence—Epirubicin—stomach cancer	0.000283	0.000392	CcSEcCtD
Acamprosate—Anorexia—Doxorubicin—stomach cancer	0.000281	0.000389	CcSEcCtD
Acamprosate—Nausea—Docetaxel—stomach cancer	0.000281	0.000389	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—stomach cancer	0.000281	0.000389	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—stomach cancer	0.000281	0.000389	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methotrexate—stomach cancer	0.000279	0.000386	CcSEcCtD
Acamprosate—Decreased appetite—Epirubicin—stomach cancer	0.000277	0.000384	CcSEcCtD
Acamprosate—Hypotension—Doxorubicin—stomach cancer	0.000276	0.000382	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000275	0.000381	CcSEcCtD
Acamprosate—Constipation—Epirubicin—stomach cancer	0.000273	0.000377	CcSEcCtD
Acamprosate—Pain—Epirubicin—stomach cancer	0.000273	0.000377	CcSEcCtD
Acamprosate—Nausea—Capecitabine—stomach cancer	0.000272	0.000376	CcSEcCtD
Acamprosate—Urticaria—Methotrexate—stomach cancer	0.000271	0.000375	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—stomach cancer	0.000269	0.000373	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—stomach cancer	0.000269	0.000373	CcSEcCtD
Acamprosate—SLC36A1—lymph node—stomach cancer	0.000269	0.0418	CbGeAlD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000269	0.000372	CcSEcCtD
Acamprosate—GABRB3—pancreas—stomach cancer	0.000268	0.0417	CbGeAlD
Acamprosate—Insomnia—Doxorubicin—stomach cancer	0.000267	0.000369	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—HSPA8—stomach cancer	0.000266	0.000982	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—stomach cancer	0.000265	0.000978	CbGpPWpGaD
Acamprosate—Paraesthesia—Doxorubicin—stomach cancer	0.000265	0.000367	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—RBP4—stomach cancer	0.000264	0.000972	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—stomach cancer	0.000264	0.000972	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—PRKCB—stomach cancer	0.000263	0.00097	CbGpPWpGaD
Acamprosate—Dyspnoea—Doxorubicin—stomach cancer	0.000263	0.000364	CcSEcCtD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	0.000263	0.000969	CbGpPWpGaD
Acamprosate—Feeling abnormal—Epirubicin—stomach cancer	0.000263	0.000364	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000263	0.000968	CbGpPWpGaD
Acamprosate—Somnolence—Doxorubicin—stomach cancer	0.000262	0.000363	CcSEcCtD
Acamprosate—Gastrointestinal pain—Epirubicin—stomach cancer	0.000261	0.000361	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—HSPA8—stomach cancer	0.00026	0.000957	CbGpPWpGaD
Acamprosate—Dyspepsia—Doxorubicin—stomach cancer	0.00026	0.000359	CcSEcCtD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	0.000258	0.000951	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	0.000257	0.000949	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—FYN—stomach cancer	0.000257	0.000946	CbGpPWpGaD
Acamprosate—Decreased appetite—Doxorubicin—stomach cancer	0.000256	0.000355	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—JUN—stomach cancer	0.000255	0.00094	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000255	0.000353	CcSEcCtD
Acamprosate—Urticaria—Epirubicin—stomach cancer	0.000253	0.000351	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—stomach cancer	0.000252	0.000349	CcSEcCtD
Acamprosate—Pain—Doxorubicin—stomach cancer	0.000252	0.000349	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—stomach cancer	0.000252	0.000349	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—stomach cancer	0.000252	0.000349	CcSEcCtD
Acamprosate—Hypersensitivity—Methotrexate—stomach cancer	0.000251	0.000347	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—FYN—stomach cancer	0.00025	0.000922	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.00025	0.000921	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—JUN—stomach cancer	0.000249	0.000917	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.000247	0.000912	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MAPK3—stomach cancer	0.000247	0.000911	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—stomach cancer	0.000247	0.00091	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—APC—stomach cancer	0.000246	0.000906	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000245	0.000904	CbGpPWpGaD
Acamprosate—Asthenia—Methotrexate—stomach cancer	0.000244	0.000338	CcSEcCtD
Acamprosate—Feeling abnormal—Doxorubicin—stomach cancer	0.000243	0.000337	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK8—stomach cancer	0.000241	0.00089	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000241	0.000334	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—stomach cancer	0.000241	0.000334	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—stomach cancer	0.000241	0.000886	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—JUN—stomach cancer	0.000239	0.000882	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HSPA8—stomach cancer	0.000238	0.000878	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK8—stomach cancer	0.000235	0.000867	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MAPK1—stomach cancer	0.000235	0.000867	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.000235	0.000867	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—EGFR—stomach cancer	0.000235	0.000867	CbGpPWpGaD
Acamprosate—Hypersensitivity—Epirubicin—stomach cancer	0.000235	0.000325	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—stomach cancer	0.000234	0.000324	CcSEcCtD
Acamprosate—Abdominal pain—Doxorubicin—stomach cancer	0.000233	0.000323	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—stomach cancer	0.000233	0.000323	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—stomach cancer	0.000233	0.000323	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000232	0.000854	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—APOA1—stomach cancer	0.00023	0.000848	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.00023	0.000848	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—PRKCB—stomach cancer	0.000229	0.000846	CbGpPWpGaD
Acamprosate—Asthenia—Epirubicin—stomach cancer	0.000229	0.000317	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—HSPB1—stomach cancer	0.000227	0.000836	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGTR2—stomach cancer	0.000227	0.000836	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—HRAS—stomach cancer	0.000227	0.000835	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	0.000226	0.000831	CbGpPWpGaD
Acamprosate—Pruritus—Epirubicin—stomach cancer	0.000226	0.000312	CcSEcCtD
Acamprosate—Dizziness—Methotrexate—stomach cancer	0.000225	0.000312	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—BMP2—stomach cancer	0.000224	0.000827	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—F2R—stomach cancer	0.000224	0.000827	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—stomach cancer	0.000224	0.000826	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—PRKCB—stomach cancer	0.000224	0.000824	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—HRAS—stomach cancer	0.000221	0.000814	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—stomach cancer	0.000221	0.000814	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKR1C3—stomach cancer	0.000221	0.000813	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR1A—stomach cancer	0.000218	0.000805	CbGpPWpGaD
Acamprosate—Diarrhoea—Epirubicin—stomach cancer	0.000218	0.000302	CcSEcCtD
Acamprosate—Hypersensitivity—Doxorubicin—stomach cancer	0.000217	0.000301	CcSEcCtD
Acamprosate—Vomiting—Methotrexate—stomach cancer	0.000217	0.0003	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000215	0.000794	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—stomach cancer	0.000215	0.000793	CbGpPWpGaD
Acamprosate—Rash—Methotrexate—stomach cancer	0.000215	0.000297	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—stomach cancer	0.000215	0.000297	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000214	0.00079	CbGpPWpGaD
Acamprosate—Headache—Methotrexate—stomach cancer	0.000213	0.000295	CcSEcCtD
Acamprosate—Asthenia—Doxorubicin—stomach cancer	0.000212	0.000293	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PRKCB—stomach cancer	0.000211	0.000779	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ANXA1—stomach cancer	0.000211	0.000777	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK3—stomach cancer	0.000211	0.000777	CbGpPWpGaD
Acamprosate—Dizziness—Epirubicin—stomach cancer	0.000211	0.000292	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	0.000209	0.000771	CbGpPWpGaD
Acamprosate—Pruritus—Doxorubicin—stomach cancer	0.000209	0.000289	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—MET—stomach cancer	0.000207	0.000763	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK3—stomach cancer	0.000206	0.000758	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.000205	0.000756	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB1—stomach cancer	0.000204	0.000753	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6ST—stomach cancer	0.000203	0.000747	CbGpPWpGaD
Acamprosate—Vomiting—Epirubicin—stomach cancer	0.000203	0.000281	CcSEcCtD
Acamprosate—Nausea—Methotrexate—stomach cancer	0.000202	0.00028	CcSEcCtD
Acamprosate—Diarrhoea—Doxorubicin—stomach cancer	0.000202	0.000279	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MET—stomach cancer	0.000202	0.000744	CbGpPWpGaD
Acamprosate—Rash—Epirubicin—stomach cancer	0.000201	0.000278	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—stomach cancer	0.000201	0.000278	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK1—stomach cancer	0.000201	0.00074	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.0002	0.000737	CbGpPWpGaD
Acamprosate—Headache—Epirubicin—stomach cancer	0.0002	0.000276	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—IL6ST—stomach cancer	0.000198	0.000729	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000198	0.000728	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—stomach cancer	0.000198	0.000728	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK1—stomach cancer	0.000196	0.000721	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RPS6—stomach cancer	0.000195	0.000719	CbGpPWpGaD
Acamprosate—Dizziness—Doxorubicin—stomach cancer	0.000195	0.00027	CcSEcCtD
Acamprosate—GABRG2—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000194	0.000715	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SMAD4—stomach cancer	0.000193	0.000711	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PRKCB—stomach cancer	0.000192	0.000708	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6ST—stomach cancer	0.000191	0.000705	CbGpPWpGaD
Acamprosate—GABRB3—endocrine gland—stomach cancer	0.000189	0.0294	CbGeAlD
Acamprosate—Nausea—Epirubicin—stomach cancer	0.000189	0.000262	CcSEcCtD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.000189	0.000696	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SMAD4—stomach cancer	0.000188	0.000693	CbGpPWpGaD
Acamprosate—Vomiting—Doxorubicin—stomach cancer	0.000188	0.00026	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—HRAS—stomach cancer	0.000186	0.000686	CbGpPWpGaD
Acamprosate—Rash—Doxorubicin—stomach cancer	0.000186	0.000257	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—stomach cancer	0.000186	0.000257	CcSEcCtD
Acamprosate—Headache—Doxorubicin—stomach cancer	0.000185	0.000256	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6R—stomach cancer	0.000184	0.000678	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FYN—stomach cancer	0.000183	0.000675	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—stomach cancer	0.000182	0.000672	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6R—stomach cancer	0.000181	0.000667	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—stomach cancer	0.000181	0.000666	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HBEGF—stomach cancer	0.000179	0.000661	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—stomach cancer	0.000179	0.00066	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FYN—stomach cancer	0.000179	0.000658	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—MAPK1—stomach cancer	0.000178	0.000654	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000177	0.000652	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6R—stomach cancer	0.000176	0.00065	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—stomach cancer	0.000175	0.000243	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—stomach cancer	0.000173	0.000637	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—stomach cancer	0.000173	0.000636	CbGpPWpGaD
Acamprosate—GABRB3—liver—stomach cancer	0.000171	0.0265	CbGeAlD
Acamprosate—GRM5—Signaling by GPCR—IL6R—stomach cancer	0.000171	0.000629	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—RHOA—stomach cancer	0.00017	0.000626	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.00017	0.000625	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—JUN—stomach cancer	0.000168	0.00062	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—stomach cancer	0.000168	0.00062	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB2—stomach cancer	0.000165	0.00061	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—MAPK1—stomach cancer	0.000165	0.000608	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.000165	0.000607	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—RHOA—stomach cancer	0.000163	0.000602	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PPP2R1A—stomach cancer	0.000162	0.000598	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—stomach cancer	0.000161	0.000594	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.000161	0.000592	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—RHOA—stomach cancer	0.000159	0.000587	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—stomach cancer	0.000159	0.000587	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—stomach cancer	0.000157	0.000579	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000154	0.000569	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—RHOA—stomach cancer	0.000154	0.000568	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PRKCB—stomach cancer	0.000151	0.000558	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—ERBB2—stomach cancer	0.000151	0.000558	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SMAD4—stomach cancer	0.000151	0.000555	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.00015	0.000554	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—stomach cancer	0.000149	0.000549	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PRKCB—stomach cancer	0.000149	0.000548	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MET—stomach cancer	0.000148	0.000544	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CDK4—stomach cancer	0.000148	0.000544	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ERBB2—stomach cancer	0.000147	0.000544	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	0.000146	0.000537	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—stomach cancer	0.000146	0.000537	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6ST—stomach cancer	0.000145	0.000533	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000145	0.000533	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CDK4—stomach cancer	0.000144	0.000531	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—stomach cancer	0.000144	0.000531	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FYN—stomach cancer	0.000143	0.000527	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—HRAS—stomach cancer	0.000143	0.000525	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—stomach cancer	0.000142	0.000523	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6ST—stomach cancer	0.000141	0.00052	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—stomach cancer	0.00014	0.000515	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK3—stomach cancer	0.000139	0.000513	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—MAPK1—stomach cancer	0.000136	0.000499	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—JUN—stomach cancer	0.000136	0.000499	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.000135	0.000499	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—stomach cancer	0.000135	0.000499	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGFR2—stomach cancer	0.000134	0.000495	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—stomach cancer	0.000134	0.000495	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.000133	0.00049	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—HRAS—stomach cancer	0.000132	0.000488	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK1—stomach cancer	0.000132	0.000488	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—stomach cancer	0.000131	0.000482	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCB—stomach cancer	0.00013	0.000479	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—stomach cancer	0.00013	0.000478	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6R—stomach cancer	0.000129	0.000476	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—stomach cancer	0.000126	0.000466	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6R—stomach cancer	0.000126	0.000464	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—stomach cancer	0.000124	0.000457	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—stomach cancer	0.000123	0.000454	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IRS2—stomach cancer	0.000123	0.000453	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—stomach cancer	0.000121	0.000445	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—stomach cancer	0.00012	0.000443	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CAV1—stomach cancer	0.000119	0.000439	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOA1—stomach cancer	0.000119	0.000438	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	0.000118	0.000436	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MAPK1—stomach cancer	0.000118	0.000436	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RHOA—stomach cancer	0.000117	0.00043	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—stomach cancer	0.000117	0.000429	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.000116	0.000428	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MAPK1—stomach cancer	0.000115	0.000425	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RHOA—stomach cancer	0.000114	0.000419	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—stomach cancer	0.000114	0.000419	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCB—stomach cancer	0.000113	0.000418	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6ST—stomach cancer	0.000113	0.000416	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000113	0.000415	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000111	0.000407	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK3—stomach cancer	0.00011	0.000406	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HRAS—stomach cancer	0.000109	0.000401	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.000109	0.000401	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APC—stomach cancer	0.000109	0.0004	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ERBB2—stomach cancer	0.000108	0.000398	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK3—stomach cancer	0.000107	0.000396	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.000107	0.000393	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—stomach cancer	0.000106	0.000392	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ERBB2—stomach cancer	0.000105	0.000388	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK1—stomach cancer	0.000105	0.000387	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—stomach cancer	0.000105	0.000386	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK3—stomach cancer	0.000104	0.000383	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK1—stomach cancer	0.000102	0.000377	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—stomach cancer	0.000102	0.000377	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000102	0.000375	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—stomach cancer	0.000101	0.000374	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6R—stomach cancer	0.000101	0.000371	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MAPK1—stomach cancer	9.99e-05	0.000368	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—stomach cancer	9.91e-05	0.000365	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK1—stomach cancer	9.89e-05	0.000365	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—stomach cancer	9.89e-05	0.000365	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—stomach cancer	9.66e-05	0.000356	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—stomach cancer	9.66e-05	0.000356	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HRAS—stomach cancer	9.49e-05	0.00035	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—stomach cancer	9.45e-05	0.000348	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—stomach cancer	9.44e-05	0.000348	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—stomach cancer	9.34e-05	0.000344	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	9.33e-05	0.000344	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—stomach cancer	9.26e-05	0.000341	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—stomach cancer	9.25e-05	0.000341	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RHOA—stomach cancer	9.1e-05	0.000336	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—stomach cancer	9.03e-05	0.000333	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—stomach cancer	9.01e-05	0.000332	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MAPK1—stomach cancer	8.74e-05	0.000322	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—stomach cancer	8.58e-05	0.000316	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOA1—stomach cancer	8.53e-05	0.000314	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB2—stomach cancer	8.43e-05	0.000311	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—stomach cancer	8.42e-05	0.00031	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOA1—stomach cancer	8.38e-05	0.000309	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—stomach cancer	8.31e-05	0.000306	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—stomach cancer	8.23e-05	0.000303	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—stomach cancer	8.21e-05	0.000303	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—stomach cancer	8.19e-05	0.000302	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—stomach cancer	8.17e-05	0.000301	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—stomach cancer	8.11e-05	0.000299	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—stomach cancer	8.06e-05	0.000297	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—stomach cancer	8.03e-05	0.000296	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—stomach cancer	8.02e-05	0.000296	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—stomach cancer	7.99e-05	0.000295	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—stomach cancer	7.94e-05	0.000293	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK3—stomach cancer	7.87e-05	0.00029	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—stomach cancer	7.86e-05	0.00029	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1B—stomach cancer	7.81e-05	0.000288	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MAPK1—stomach cancer	7.8e-05	0.000287	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK3—stomach cancer	7.67e-05	0.000283	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MAPK1—stomach cancer	7.66e-05	0.000282	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—stomach cancer	7.6e-05	0.00028	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK1—stomach cancer	7.48e-05	0.000276	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—stomach cancer	7.48e-05	0.000276	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—stomach cancer	7.45e-05	0.000274	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUN—stomach cancer	7.43e-05	0.000274	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOA1—stomach cancer	7.32e-05	0.00027	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK1—stomach cancer	7.3e-05	0.000269	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—stomach cancer	7.29e-05	0.000269	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—stomach cancer	7.23e-05	0.000266	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1A—stomach cancer	7.2e-05	0.000266	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—stomach cancer	7.13e-05	0.000263	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—stomach cancer	7.07e-05	0.000261	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—stomach cancer	7.03e-05	0.000259	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—stomach cancer	7.01e-05	0.000258	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—stomach cancer	6.95e-05	0.000256	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—stomach cancer	6.89e-05	0.000254	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—stomach cancer	6.76e-05	0.000249	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MAPK1—stomach cancer	6.69e-05	0.000247	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—stomach cancer	6.64e-05	0.000245	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—stomach cancer	6.49e-05	0.000239	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—stomach cancer	6.43e-05	0.000237	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—stomach cancer	6.26e-05	0.000231	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—stomach cancer	6.15e-05	0.000227	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK3—stomach cancer	6.14e-05	0.000226	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—stomach cancer	6.01e-05	0.000221	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—stomach cancer	5.97e-05	0.00022	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—stomach cancer	5.86e-05	0.000216	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK1—stomach cancer	5.84e-05	0.000215	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—stomach cancer	5.84e-05	0.000215	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—stomach cancer	5.8e-05	0.000214	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—stomach cancer	5.75e-05	0.000212	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—stomach cancer	5.61e-05	0.000207	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—stomach cancer	5.52e-05	0.000203	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—stomach cancer	5.37e-05	0.000198	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—stomach cancer	5.07e-05	0.000187	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—stomach cancer	4.91e-05	0.000181	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—stomach cancer	4.69e-05	0.000173	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—stomach cancer	4.49e-05	0.000165	CbGpPWpGaD
